Case Studies
New Approach Methodologies (NAM’s): Emerging Human-Based Disease Models
Designed to better mimic human biology, NAMs promise improved predictive accuracy for disease models, offering more relevant insights into human health.
How Huvepharma Scaled Global Quality and Compliance with ETQ Reliance®
Discover how a fast-growing global pharma leader unified 12,000+ users, accelerated compliance, and maintained quality across 90+ global sites.
Accelerator™ Drug Development: Driving Global Clinical Research Success Through Integrated Governance
Coordinating large-scale clinical research programs across multiple geographies, vendors, and timelines often creates complexity and risk.
Accelerator™ Drug Development: Collaborative Timeline Management Drives Speed and Simplicity in Global Vaccine Trial
Coordinating a global Phase III vaccine study across 6,000+ subjects, 170 sites, and 20+ countries presents extraordinary logistical and regulatory challenges from cold-chain distribution to regional labeling and site activation.
Accelerator™ Drug Development: Streamlining Preclinical Pathways for a Fast Transition to First-in-Human Trials
For emerging biotech companies, the path from preclinical development to first-in-human (FIH) trials can define the future of a therapy. Challenges such as regulatory hurdles, incomplete API characterization,and inefficient study design often lead to costly delays and lost momentum.
Streamline Bioprocessing with Ready-to-Use Buffer Solutions
Rapid growth can bring rapid challenges. When a leading Contract Development and Manufacturing Organization (CDMO) faced an unexpected surge in demand for one of their client’s newly approved therapeutics, they encountered significant bottlenecks in buffer preparation
